Rahul Gosain, Director of Regional Infusion Services and Medical Director at Wilmot Cancer Institute, shared a post on LinkedIn:
“2025 approvals: Summary of 5 new drugs/indications in Breast Cancer & GynOnc by Santa aka FDA
1. DatoDXd
2. TDXd x2
3. Imlunestrant
4. Avutometinib/Defactinib: Ovarian Ca.”
More posts featuring Rahul Gosain on OncoDaily.